NorthRock Partners LLC Sells 3,151 Shares of The Procter & Gamble Company (NYSE:PG)

NorthRock Partners LLC cut its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 17.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,233 shares of the company’s stock after selling 3,151 shares during the period. NorthRock Partners LLC’s holdings in Procter & Gamble were worth $2,638,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Itau Unibanco Holding S.A. acquired a new position in Procter & Gamble in the 2nd quarter worth $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at approximately $29,000. Ruedi Wealth Management Inc. boosted its position in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the last quarter. POM Investment Strategies LLC bought a new stake in shares of Procter & Gamble in the second quarter worth $34,000. Finally, Quest Partners LLC bought a new position in Procter & Gamble in the second quarter valued at $36,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

NYSE:PG traded up $0.26 on Tuesday, hitting $165.34. The company had a trading volume of 461,721 shares, compared to its average volume of 6,609,458. The firm has a 50 day moving average of $171.52 and a two-hundred day moving average of $168.13. The stock has a market capitalization of $389.38 billion, a price-to-earnings ratio of 28.46, a PEG ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period last year, the firm posted $1.83 earnings per share. The business’s revenue for the quarter was down .6% on a year-over-year basis. On average, research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.43%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s payout ratio is presently 69.48%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on PG shares. Citigroup upped their target price on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price target for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Finally, JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Nine analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Insider Activity

In other news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Susan Street Whaley sold 450 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares in the company, valued at approximately $2,212,043.84. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 385,771 shares of company stock valued at $65,610,975. Company insiders own 0.18% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.